Recipharm AB acquires Abbott Manufacturing Site in Spain

05-Oct-2010 - Spain

Recipharm AB announced that they have acquired Abbott’s (formerly Solvay Pharmaceuticals) manufacturing site in Parets, close to Barcelona, Spain for an undisclosed sum. Parets produces solid dose, sterile ointments, oral liquids, aerosols and topical products. The site, which has benefited from high levels of investment in recent years, is well suited to the flexible requirements of a contract manufacturing operation, already servicing a number of companies. The newly acquired business will be called Recipharm Parets SL.

This move further enhances Recipharm’s capabilities, providing a base in the strategically important Spanish market, whilst bringing new customer relationships into the Recipharm Group. It also reinforces Recipharm’s strategic goal to become one of the world’s leading Contract Development and Manufacturing Organisations (CDMO), offering a ‘one-stop shop’ for the development and manufacturing of both small and large molecule biopharmaceuticals.

Recipharm will continue to produce all Abbott products currently manufactured at the site. Recipharm also intends to retain all existing employees.

Other news from the department manufacturing

Most read news

More news from our other portals

Last viewed contents

Two colour technique reveals how X-ray lasers damage biomolecules - Step to a fuller understanding of how X-ray flashes modify the structure of proteins

Two colour technique reveals how X-ray lasers damage biomolecules - Step to a fuller understanding of how X-ray flashes modify the structure of proteins

QIAGEN acquires Genoox - "As part of QIAGEN, we can together drive the next wave of precision medicine"

QIAGEN acquires Genoox - "As part of QIAGEN, we can together drive the next wave of precision medicine"

D-Cycloserine Reduces Cocaine-Seeking Behavior in "Addicted" Mice - Antibiotic that appears to control phobias may also be useful in treating addiction

Thermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research Across Europe

Aeras awarded €11.7 million ($16 million) grant from Dutch government

Thermal microscopy of single cells

Thermal microscopy of single cells

Using barcodes to trace cell development - Method will facilitate whole new insights into the development of various tissues as well as cancer

Using barcodes to trace cell development - Method will facilitate whole new insights into the development of various tissues as well as cancer

Merck Millipore offers quick tests for EHEC in food - Easy to use detection for food manufacturers and researchers

One Year of GATTEX(TM) Therapy Safely Reduces Parenteral Nutrition Dependence for Patients with Short Bowel Syndrome - Results Presented at American College of Gastroenterology Annual Meeting Show Majority of Responders Continued to Benefit from GATTEX in Phase 3-Extension Study

Unraveling the genome in 3D-space - Groundbreaking method to map contact points between replicated DNA molecules, thereby elucidating how the genome is folded inside the nucleus of human cells

Unraveling the genome in 3D-space - Groundbreaking method to map contact points between replicated DNA molecules, thereby elucidating how the genome is folded inside the nucleus of human cells

MorphoSys Appoints New Head of Preclinical Development - MorphoSys Further Strengthens its Proprietary Development Team